Effect of Individualized PEEP on Postoperative Pulmonary Complication in Bariatrics

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16+
SponsorAin Shams University

About this trial

Ventilation with low tidal volume and high PEEP (positive end expiratory pressure) has been shown to improve oxygenation in patients with ARDS (acute respiratory distress syndrome). In obese patients undergoing laparoscopic bariatric surgeries, the risk of postoperative pulmonary complications (PPCs) increases significantly with general anesthesia. Previous studies have shown that protective lung ventilation strategies could improve intraoperative oxygenation and lung mechanics.

In this study would compare the effect of optimum individualized high PEEP versus standard PEEP - on postoperative pulmonary complications

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patients were eligible for participation if the met the following criteria

Age between 18 and 60 years old.

Body mass index > 40

Laparoscopic bariatric elective surgery under general anesthesia.

Disqualifiers

Previous lung surgery

ASA status III or IV.

Moderate to severe obstructive or restrictive lung disease .

Persistant intraoperative hemodynamic instability .

Trial design

Design model

Parallel

Treatments tested in this trial

  • titated PEEP to best static compliance

    Other intervention

    the Intraoperative PEEP will be titrated to best static compliance for each patient

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: titrate PEEPExperimental treatment 1 intervention
Group B: standardActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

postoperative pulmonary complication

pneumonia-atelactasis-bronchospasm-respiratory failure

Time frame
postoperative 10 days after surgery

Secondary outcomes

1

Pulmonary functions test

This test includes these values :FVC (forced vital capacity ) FEV1( forced expiratory volume in one sec ) FEV1% and FVC%

Time frame
postoperative 1st , 3rd and 5th day

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.